Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colesevelam versus placebo in obese men with impaired glucose tolerance or newly diagnosed type 2 diabetes
NL-OMON24802Not yet recruiting
- Sponsor
- No
- Start
- May 2009
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, double-blind trial in prediabetes and type 2 diabetes mellitus (T2DM) comparing Colesevelam with Placebo (2 arms). Primary endpoint: Change in bile acid composition. Planned start May 2009; status: not yet recruiting.
02
Drugs
colesevelam
03
Conditions
prediabetestype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON24802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24802.